Question-and-Answer Session
Operator
(Operator Instructions)
And your first question will come from the line of Rich Silver with Lehman Brothers.
Rich Silver - Lehman Brothers
Good afternoon.
Bob Myers
Hi, Rich.
Rich Silver - Lehman Brothers
Hi. Could you provide a little bit more detail on the managed care discussions? You did mention that there is no need for prior authorization with any customers, but perhaps discussion of tier-3 status and how for along you are in the process of the managed care discussions?
Bob Myers
Hi, Rich. It's Bob. It is still very early in the launch. So I'd rather not get in too much detail in managed care discussions. I will say that, what we're seeing is that almost exactly what we expected which is tier-3 and our coverage is very good in terms of not requiring a prior authorization, which is what we expected. And it puts us on a similar plain build with other branded products, others SSRIs or SNRIs. So, from a managed care perspective, it's very early but exactly what we have planned for.
Rich Silver - Lehman Brothers
And as far as, the $40 million to $60 million on changed guidance, can you now give us a better sense of how heavily year end loaded that number is? We know that it obviously is second half end loaded. But at this point, with one quarter under your belt and out there and you're getting obviously a little bit more feedback, any additional clarity on the progression and what you might even be expecting in the current quarter?
Matt Fust
Hi Rich, it's Matt. As Bob mentioned, we're still so early in the launch with just a few weeks of our IMS prescription data in hand. We're not yet at this time to provide more granularity on what we think the growth progression will be over the course of a year. We would agree with your assessment and we expect growth throughout the year and certainly expect the second half to be considerably larger than the first. But beyond that it's just too early to have a sense for what the trajectory will look like.
Rich Silver - Lehman Brothers
Okay. Thanks.
Operator
Your next question will come from the line of Marc Goodman with Credit Suisse.
Marc Goodman - Credit Suisse
Yeah. First question is on the stocking for LUVOX, you had mentioned $3 million. Will there be further stocking in this quarter?
- To read the full transcript on Seeking Alpha, click here »
